Zembrace Symtouch
Product Images NDC 67857-809

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Zembrace Symtouch (NDC 67857-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Promius Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan-structure (Zembrace 01)

FDA Label Image

Ifu1 (Zembrace 02)

FDA Label Image

Ifu2 (Zembrace 03)

The text appears to be describing features of a medication product called "Med ZEMBRACE" and a delivery device called "SymTouch". The product features a red cap viewing window, a yellow and red color scheme, and a NeedleGuard and plunger rod. It is unclear what the medication is for or how it is administered.*

FDA Label Image

Ifu3 (Zembrace 04)

FDA Label Image

Ifu4 (Zembrace 05)

FDA Label Image

Ifu5 (Zembrace 06)

The text is describing the materials needed for administering ZEMBRACE and SymTouch injections. The materials include alcohol, sterile cotton ball, puncture-resistant swab or gauze, and a sharps container. It is likely a medical instruction manual or guide.*

FDA Label Image

Ifu6 (Zembrace 07)

FDA Label Image

Ifu7 (Zembrace 08)

FDA Label Image

Ifu8 (Zembrace 09)

FDA Label Image

Ifu9 (Zembrace 10)

FDA Label Image

Ifu10 (Zembrace 11)

FDA Label Image

Ifu11 (Zembrace 12)

The Yellow Needle Guard is a safety mechanism that is designed to be locked over the needle. Additional information is not available.*

FDA Label Image

Ifu12 (Zembrace 13)

FDA Label Image

Ifu13 (Zembrace 14)

FDA Label Image

Ifu14 (Zembrace 15)

FDA Label Image

Auto-injector Label (Zembrace 16)

Zembrace 3 mg is a prescription medication in the form of an autoinjector containing a prefilled syringe of 0.5 mL solution with 4.2 mg of sumatriptan succinate. The medication is intended for subcutaneous use only and is equivalent to 3 mg of sumatriptan base. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from light. Zembrace 3 mg is distributed by Promius Pharma, LLC, Princeton, NJ 08540, and manufactured for Dr. Reddy's Laboratories, LTD, by Ajinomoto Althea Inc., San Diego, CA 92121.*

FDA Label Image

4-count Carton Label (partition) (Zembrace 17)

FDA Label Image

4-count Carton Label (interior) (Zembrace 18)

Zembrace is a sumatriptan injection medication. Patients can find enclosed instructions for ZEMBRACE SymTouch on the website www.zembrace.com to better understand this product.*

FDA Label Image

4-ct Carton Label (exterior) (Zembrace 19)

Zembrace is a subcutaneous injection used for the treatment of migraine headaches. Each autoinjector has 0.5 mL of sterile solution which contains 4.2 mg of sumatriptan succinate equivalent to 3 mg of sumatriptan base, 4.15 mg sodium chloride, and water for injection. Dosage information is available inside the package insert. It should be stored between 20°C to 25°C (68°F to 77°F) and in a light-protected area. Distributed by Promius Pharma, LLC and manufactured for Dr. Reddy’s Laboratories, LTD by Ajinomoto Althea Inc., San Diego, CA 92121.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.